Together, these findings suggest that the high Kpnβ1 and Kpnα2 expression levels in cervical cancer cells is due in part to E7-mediated inhibition of Rb, and the consequent increased activation of the Kpnβ1 and Kpnα2 promoters by E2F. The gene discussed is KPNA2; the disease is cervical carcinoma.